ConductScience.org, home

Paper41997128

Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature.

Subudhi S and 2 others. Cell, 2026. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature. Papers, record 41997128. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41997128

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature.
PubMed
Journal
Cell
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
4.5, provisional
iCite
Revised in PubMed
2026-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Subudhi SSonu
2Lee SSomin
3Jain RKRakesh K

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neovascularization, PathologicMajor topic
NeoplasmsMajor topic
Angiogenesis InhibitorsMajor topic
AngiogenesisMajor topic
Humans
Animals
Tumor Microenvironment
Immunotherapy

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 NS118929NINDS NIH HHSUnited StatesR01NS118929PubMedNIH RePORTER
U01 CA224348NCI NIH HHSUnited StatesU01CA224348PubMedNIH RePORTER
R01 CA259253NCI NIH HHSUnited StatesR01CA259253PubMedNIH RePORTER
R35 CA197743NCI NIH HHSUnited StatesR35CA197743PubMedNIH RePORTER
R01 CA269672NCI NIH HHSUnited StatesR01CA269672PubMedNIH RePORTER
U01 CA261842NCI NIH HHSUnited StatesU01CA261842PubMedNIH RePORTER

Download CSV of grants

References369

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127589843Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy.Oncotarget2016https://conductscience.org/library/papers/27589843PubMed
229508855Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/29508855PubMed
337879536
A Phase 1b Study of Ivonescimab, a Programmed Cell Death Protein-1 and Vascular Endothelial Growth Factor Bispecific Antibody, as First- or Second-Line Therapy for Advanced or Metastatic Immunotherapy-Naive NSCLC.
J Thorac Oncol2024https://conductscience.org/library/papers/37879536PubMed
431628560Models and molecular mechanisms of blood vessel co-option by cancer cells.Angiogenesis2020https://conductscience.org/library/papers/31628560PubMed
540628539Pericyte phenotype switching in cancer.Trends Cancer2025https://conductscience.org/library/papers/40628539PubMed
637059069Cancer neuroscience: State of the field, emerging directions.Cell2023https://conductscience.org/library/papers/37059069PubMed
735120598Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy.Cancer Cell2022https://conductscience.org/library/papers/35120598PubMed
89008168Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.Cell1997https://conductscience.org/library/papers/9008168PubMed
926367079Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.Biochim Biophys Acta2015https://conductscience.org/library/papers/26367079PubMed
1017021318Ranibizumab for neovascular age-related macular degeneration.N Engl J Med2006https://conductscience.org/library/papers/17021318PubMed
1138444610FOXO1 stimulates tip cell-enriched gene expression in endothelial cells.iScience2024https://conductscience.org/library/papers/38444610PubMed
1225806273Dll4/Notch1 signaling from tip/stalk endothelial cell specification to stroma-dependent lung tumor inhibition: a flavor of Dll4/Notch1 pleiotropy in tumor cell biology.Transl Lung Cancer Res2013https://conductscience.org/library/papers/25806273PubMed
1340540467Active peptides of TSP-1 inhibit retinal angiogenesis through the CD36 pathway in a rat model of choroidal neovascularization.PLoS One2025https://conductscience.org/library/papers/40540467PubMed
1436823172Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas.Nat Commun2023https://conductscience.org/library/papers/36823172PubMed
1518802153Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.J Clin Oncol2008https://conductscience.org/library/papers/18802153PubMed
1619763275VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation.PLoS One2009https://conductscience.org/library/papers/19763275PubMed
1722127927Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion.Cancer Res2012https://conductscience.org/library/papers/22127927PubMed
1839400127Spatial Multiomics Reveals Intratumoral Immune Heterogeneity with Distinct Cytokine Networks in Lung Cancer Brain Metastases.Cancer Res Commun2024https://conductscience.org/library/papers/39400127PubMed
1939019408Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumors.Biochim Biophys Acta Rev Cancer2024https://conductscience.org/library/papers/39019408PubMed
208756616Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.Mol Cell Biol1996https://conductscience.org/library/papers/8756616PubMed

See all 369 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42974100Cancer-associated fibroblasts and innate immune cells: orchestrators of the immunosuppressive tumor microenvironment.Front Immunol2026https://conductscience.org/library/papers/42974100PubMed
42961010Vascular normalization confers an endothelial immune suppressive gene expression profile.Mol Oncol2026https://conductscience.org/library/papers/42961010PubMed
42862474Linking preclinical models with functional imaging and artificial intelligence to decode tumor angiogenesis.Pharmacol Rep2026https://conductscience.org/library/papers/42862474PubMed
42699645Transrectal ultrasonographic parameters combined with total serum exosomes for the assessment of bone metastases in prostate cancer.Open Life Sci2026https://conductscience.org/library/papers/42699645PubMed
42543810Glioma-Associated Microglia Augment Neuronal Hyper-Excitability in Glioma.Brain Tumor Res Treat2026https://conductscience.org/library/papers/42543810PubMed
42192869Hypoxia Impairs CD8+ T Cell Fitness and Is Associated with a Dysfunctional CD8+ T Cell State in Pancreatic Cancer.Cancers (Basel)2026https://conductscience.org/library/papers/42192869PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41997128

GET https://conductscience.org/api/papers/v1/41997128/references?page=2